Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Medtronic
Harvard Business School
McKesson
Colorcon

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Warfarin sodium - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for warfarin sodium and what is the scope of patent protection?

Warfarin sodium is the generic ingredient in five branded drugs marketed by Bristol Myers Squibb, Pharm Res Assoc, Upsher Smith Labs, Abbott, Amneal Pharms, Barr, Invagen Pharms, Ipca Labs Ltd, Mylan, Pliva, Taro, Usl Pharma, Watson Labs, Yaopharma Co Ltd, and Zydus Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for warfarin sodium. Twenty-nine suppliers are listed for this compound.

Drug Prices for warfarin sodium

See drug prices for warfarin sodium

Drug Sales Revenue Trends for warfarin sodium

See drug sales revenues for warfarin sodium

Recent Clinical Trials for warfarin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wuhan Asia Heart HospitalN/A
The Young Investigator Group of Cardiovascular ResearchPhase 3
Wolfson Medical CenterN/A

See all warfarin sodium clinical trials

Pharmacology for warfarin sodium
Drug ClassVitamin K Antagonist
Mechanism of ActionVitamin K Inhibitors
Synonyms for warfarin sodium
(+-)-Warfarin sodium
12795-55-0
129-06-6
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt
2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt (1:1)
2H-1-Benzopyran-2-one,4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-, sodium salt (9CI)
3-(3-Oxo-1-phenylbutyl)-4-sodiooxy-2H-1-benzopyran-2-one
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin Sodiuim Salt
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin sodium salt
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin Sodium Salt
51821-81-9
5543-79-3
67430-45-9
859043-62-2
A805899
AB0013224
AB1009293
AC-19972
AC-8078
AKOS015951251
AKOS015955387
Aldocumar
AN-19116
AN-8368
API0004610
Athrombin
AX8156592
BC215937
BCP20702
C-20012
C19H15NaO4
C19H15O4.Na
CAS-129-06-6
Caswell No. 903A
CC-35635
CHEMBL1200879
Coumadan Sodico
Coumadin (TN)
Coumadin sodium
Coumadin sodium|||4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-Benzopyran-2-one, sodium salt (1:1)
Coumadine
Coumafene sodium
Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-, sodium salt
CPD000058849
CTK5A3600
D00564
Dicusat
DSSTox_CID_15010
DSSTox_GSID_35010
DSSTox_RID_79236
DTXSID7035010
EINECS 204-929-4
EINECS 226-909-4
EPA Pesticide Chemical Code 086003
H742
HMS2233P10
HMS3259G13
HMS3369M10
J-005647
J10262
Jantoven
Jantoven (TN)
KB-62273
KYITYFHKDODNCQ-UHFFFAOYSA-M
LS-55086
Marevam
Marevan
MCULE-2794487450
MLS001074341
MolPort-002-130-141
NC00490
NCGC00255556-01
Orfarin
Ratsul soluble
SAM002548943
SAM002554882
SCHEMBL7826
Simarc
SMR000058849
sodium 2-oxidanylidene-3-(3-oxidanylidene-1-phenyl-butyl)chromen-4-olate
sodium 2-oxo-3-(3-oxo-1-phenyl-butyl)chromen-4-olate
sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-1-benzopyran-4-olate
Sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-olate
Sodium coumadin
Sodium warfarin
sodium warfarin(1-)
Sodium, ((3-(alpha-acetonylbenzyl)-2-oxo-2H-1-benzopyran-4-yl)oxy)-
ST24031985
Tintorane
Tox21_301545
UniWarfin
Varfine
W0005
Waran
Warcoumin
Warfarin sodium (contains Isopropyl Alcohol)
Warfarin sodium (USP)
Warfarin sodium [USAN]
Warfarin sodium [USP]
Warfarin sodium clathrate
Warfarin sodium salt
warfarin-sodium
Warfarin, sodium deriv
Warfarin, sodium deriv.
Warfarin, sodium salt
Warfilone
Zoocoumarin sodium salt

US Patents and Regulatory Information for warfarin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs JANTOVEN warfarin sodium TABLET;ORAL 040416-005 Oct 2, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms WARFARIN SODIUM warfarin sodium TABLET;ORAL 202202-002 Mar 4, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs JANTOVEN warfarin sodium TABLET;ORAL 040416-003 Oct 2, 2003 AB RX No No   Start Trial   Start Trial   Start Trial
Abbott PANWARFIN warfarin sodium TABLET;ORAL 017020-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb COUMADIN warfarin sodium INJECTABLE;INJECTION 009218-012 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Invagen Pharms WARFARIN SODIUM warfarin sodium TABLET;ORAL 090935-001 May 25, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
McKesson
Medtronic
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.